DrugDev Webinar Offers Live Demo of New SaaS Version of Site Activation Technology to Decrease Clinical Trial Startup Time from Months to Weeks
SaaS technology based on years of proven best practices for clinical trial agreement (CTA) negotiations, budget development and essential regulatory document collection
KING OF PRUSSIA, PA (PRWEB) March 11, 2016
DrugDev will host an educational webinar to unveil the new SaaS version of its Site Activation technology (read announcement) which enables internal sponsor and CRO teams to reduce the average time of global site startup from several months to just a few weeks. Based on years of proven best practices for successful and efficient CTA negotiations, budget development and essential reg doc collection, the SaaS module is an essential part of the unified DrugDev clinical operations suite.
Webinar: New SaaS Technology: Activate Sites in Weeks Instead of Months
Date: March 17, 2016
Time: 12:00-1:00pm ET
This webinar is complimentary
Attendees will learn how the DrugDev Site Activation module makes the interactions with sites during efeasibility, contracting and budget negotiations, and the collection and maintenance of essential site regulatory documents more efficient with historical contract terms provided, secure document exchange, and trackers that automate the contracting and essential site document collection process. Workflow optimization is easily customized and transparent reporting across all active trials allows sponsors to easily track progress and identify challenges and bottlenecks.
The webinar will be hosted by Melissa “Liss” Easy, DrugDev Founder and President of Site Startup, with a live technology demo provided by DrugDev Systems Administrator Jeremy Hall.
For more details, read what top pharmaceutical industry publications are saying about the DrugDev Site Activation module in Clinical Informatics News and Applied Clinical Trials.
About the Presenters
DrugDev Founder and President of Site Startup Melissa “Liss” Easy oversees site activation activities for DrugDev customers. As a consultant to CROs Liss identified serious inefficiencies in the process for matching investigators to new drug protocols by CROs and sponsors, and developed the concept of DrugDev to address this industry-wide problem. Liss’s vision has enabled DrugDev to become the leading provider of technologies to improve all clinical trial operations from startup through closeout. Her honors include being named one of the PharmaVOICE 100 most inspiring people in life sciences; the Partnerships in Clinical Trials Woman of the Year; and the Philadelphia Business Journal’s Healthcare Innovator and Woman of Distinction.
DrugDev Systems Administrator Jeremy Hall’s passion is to make the clinical study process more efficient. He was instrumental in the development and launch of the DrugDev Site Activation module. Having worked for DrugDev for eight years, his experience and insights have helped customers navigate the entire clinical study startup process. Jeremy’s expertise includes budgeting, negotiating contracts, document management and systems. His insight into the site and sponsor perspective has also proven to be a great asset to the development team.
DrugDev’s unified clinical suite enables sponsors, CROs and sites to do more trials through industry-wide collaboration, standardization and a beautiful technology experience. Featuring solutions for global site payments, site identification and activation, workflow optimization, learning management, and site and patient engagement, DrugDev helps companies transform the quality and efficiency of clinical trials from startup through closeout. The company also powers the revolutionary TransCelerate Investigator Registry and Investigator Databank collaborations with the universal identifier known as the DrugDev Golden Number. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev technology at drugdev.com.